Literature DB >> 25912790

The Parkinson-associated human P5B-ATPase ATP13A2 protects against the iron-induced cytotoxicity.

Débora E Rinaldi1, Gerardo R Corradi1, Lucía Martínez Cuesta1, Hugo P Adamo2, Felicitas de Tezanos Pinto3.   

Abstract

P-type ion pumps are membrane transporters that have been classified into five subfamilies termed P1-P5. The ion transported by the P5-ATPases is not known. Five genes named ATP13A1-ATP13A5 that belong to the P5-ATPase group are present in humans. Loss-of-function mutations in the ATP13A2 gene (PARK9, OMIM 610513) underlay a form of Parkinson's disease (PD) known as the Kufor-Rakeb syndrome (KRS), which belongs to the group of syndromes of neurodegeneration with brain iron accumulation (NBIA). Here we report that the cytotoxicity induced by iron exposure was two-fold reduced in CHO cells stably expressing the ATP13A2 recombinant protein (ATP13A2). Moreover, the iron content in ATP13A2 cells was lower than control cells stably expressing an inactive mutant of ATP13A2. ATP13A2 expression caused an enlargement of lysosomes and late endosomes. ATP13A2 cells exhibited a reduced iron-induced lysosome membrane permeabilization (LMP). These results suggest that ATP13A2 overexpression improves the lysosome membrane integrity and protects against the iron-induced cell damage.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Iron; Lysosome membrane permeabilization; P(5B)-ATP13A2; P-type ATPase; Parkinson disease

Mesh:

Substances:

Year:  2015        PMID: 25912790     DOI: 10.1016/j.bbamem.2015.04.008

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

Review 1.  Parkinson's disease and iron.

Authors:  Hideki Mochizuki; Chi-Jing Choong; Kousuke Baba
Journal:  J Neural Transm (Vienna)       Date:  2020-02-05       Impact factor: 3.575

Review 2.  Coherent and Contradictory Facts, Feats and Fictions Associated with Metal Accumulation in Parkinson's Disease: Epicenter or Outcome, Yet a Demigod Question.

Authors:  Mohd Sami Ur Rasheed; Sonam Tripathi; Saumya Mishra; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2016-08-01       Impact factor: 5.590

3.  Unlocking ATP13A2/PARK9 activity.

Authors:  Shaun Martin; Tine Holemans; Peter Vangheluwe
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 4.  Iron and Neurodegeneration: Is Ferritinophagy the Link?

Authors:  Giorgio Biasiotto; Diego Di Lorenzo; Silvana Archetti; Isabella Zanella
Journal:  Mol Neurobiol       Date:  2015-10-14       Impact factor: 5.590

5.  Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78).

Authors:  Alejandro Estrada-Cuzcano; Shaun Martin; Teodora Chamova; Matthis Synofzik; Dagmar Timmann; Tine Holemans; Albena Andreeva; Jennifer Reichbauer; Riet De Rycke; Dae-In Chang; Sarah van Veen; Jean Samuel; Ludger Schöls; Thorsten Pöppel; Danny Mollerup Sørensen; Bob Asselbergh; Christine Klein; Stephan Zuchner; Albena Jordanova; Peter Vangheluwe; Ivailo Tournev; Rebecca Schüle
Journal:  Brain       Date:  2017-02       Impact factor: 13.501

Review 6.  The Roles of ATP13A2 Gene Mutations Leading to Abnormal Aggregation of α-Synuclein in Parkinson's Disease.

Authors:  Fan Zhang; Zhiwei Wu; Fei Long; Jieqiong Tan; Ni Gong; Xiaorong Li; Changwei Lin
Journal:  Front Cell Neurosci       Date:  2022-07-06       Impact factor: 6.147

Review 7.  Neurodegeneration with Brain Iron Accumulation.

Authors:  Susanne A Schneider
Journal:  Curr Neurol Neurosci Rep       Date:  2016-01       Impact factor: 5.081

8.  Brain iron accumulation affects myelin-related molecular systems implicated in a rare neurogenetic disease family with neuropsychiatric features.

Authors:  M Heidari; D M Johnstone; B Bassett; R M Graham; A C G Chua; M J House; J F Collingwood; C Bettencourt; H Houlden; M Ryten; J K Olynyk; D Trinder; E A Milward
Journal:  Mol Psychiatry       Date:  2016-01-05       Impact factor: 15.992

9.  Regulation of ATP13A2 via PHD2-HIF1α Signaling Is Critical for Cellular Iron Homeostasis: Implications for Parkinson's Disease.

Authors:  Subramanian Rajagopalan; Anand Rane; Shankar J Chinta; Julie K Andersen
Journal:  J Neurosci       Date:  2016-01-27       Impact factor: 6.167

10.  Protection against Mitochondrial and Metal Toxicity Depends on Functional Lipid Binding Sites in ATP13A2.

Authors:  Shaun Martin; Sarah van Veen; Tine Holemans; Seyma Demirsoy; Chris van den Haute; Veerle Baekelandt; Patrizia Agostinis; Jan Eggermont; Peter Vangheluwe
Journal:  Parkinsons Dis       Date:  2016-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.